BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25796205)

  • 1. Evaluation of micro-emboli in a patient with ventricular assist device support with hemolysis.
    Seguchi O; Saito K; Fukuma K; Shimamoto K; Sato T; Nakajima S; Sunami H; Kuroda K; Sato T; Watanabe T; Hata H; Yanase M; Fujita T; Kobayashi J; Nagatsuka K; Nakatani T
    J Artif Organs; 2015 Sep; 18(3):276-9. PubMed ID: 25796205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Implication of Transcranial Doppler Detection of Microembolic Signals in Patients with Heartmate II.
    Fukuma K; Seguchi O; Saito K; Kuroda K; Nakajima S; Sato T; Yanase M; Matsumoto Y; Fukushima S; Fujita T; Kobayashi J; Nagatsuka K; Fukushima N
    ASAIO J; 2018; 64(5):694-696. PubMed ID: 29251634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Microembolization in Left Ventricular Assist Device Associated Ischemic Events.
    Hassett CE; Cho SM; Rice CJ; Migdady I; Starling RC; Uchino K; Katzan IL
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104660. PubMed ID: 32044219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of hemostatic indexes in conjunction with transcranial doppler sonography in patients with ventricular assist devices.
    Wilhelm CR; Ristich J; Knepper LE; Holubkov R; Wisniewski SR; Kormos RL; Wagner WR
    Stroke; 1999 Dec; 30(12):2554-61. PubMed ID: 10582977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
    Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
    J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Thromboembolic Events in Patients with Ventricular Assist Device.
    Boehme AK; Pamboukian SV; George JF; Dillon C; Levitan EB; Griffin R; Beasley TM; McGwin G; Kirklin JK; Limdi NA
    ASAIO J; 2015; 61(6):640-7. PubMed ID: 26418204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices.
    Matsumoto Y; Fukushima S; Shimahara Y; Kawamoto N; Tadokoro N; Kuroda K; Nakajima S; Watanabe T; Seguchi O; Yanase M; Fukushima N; Shimizu H; Kobayashi J; Fujita T
    J Artif Organs; 2020 Mar; 23(1):19-26. PubMed ID: 31482437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of intracranial microembolic signals in patients with left ventricular assist devices. A prospective study.
    Nabavi DG; Georgiadis D; Mumme T; Schmid C; Mackay TG; Scheld HH; Ringelstein EB
    Stroke; 1996 May; 27(5):891-6. PubMed ID: 8623109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic Dehydrogenase in the In Vitro Evaluation of Hemolytic Properties of Ventricular Assist Device.
    Li D; Wu Q; Liu S; Chen Y; Chen H; Ruan Y; Zhang Y
    Artif Organs; 2017 Nov; 41(11):E274-E284. PubMed ID: 28722142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Are We Monitoring Brain Injuries in Patients With Left Ventricular Assist Device? A Systematic Review of Literature.
    Fan TH; Hassett CE; Migdady I; Price C; Choi CW; Katzan I; Cho SM
    ASAIO J; 2021 Feb; 67(2):149-156. PubMed ID: 33512913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
    Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
    J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Center Experience With HeartMate II Left Ventricular Assist Device Explantation.
    Tchantchaleishvili V; Cheyne C; Sherazi S; Melvin AL; Hallinan W; Chen L; Todd Massey H
    Artif Organs; 2016 Dec; 40(12):1145-1149. PubMed ID: 27076358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microembolic signal monitoring in patients with HeartMate 3 and HeartWare left ventricular assist devices: Association with antithrombotic treatment and cerebrovascular events.
    Ravenberg KK; Gabriel MM; Leotescu A; Tran AT; Grosse GM; Schuppner R; Ernst J; Lichtinghagen R; Tiede A; Werwitzke S; Bara CL; Schmitto JD; Weissenborn K; Hanke JS; Worthmann H
    Artif Organs; 2023 Feb; 47(2):370-379. PubMed ID: 36114791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
    Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
    Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ventricular assist devices in patients with mitral valve prostheses.
    Goda A; Takayama H; Koeckert M; Pak SW; Sutton EM; Cohen S; Uriel N; Jorde U; Mancini D; Naka Y
    J Card Surg; 2011 May; 26(3):334-7. PubMed ID: 21480991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support.
    Adatya S; Uriel N; Yarmohammadi H; Holley CT; Feng A; Roy SS; Reding MT; John R; Eckman P; Zantek ND
    JACC Heart Fail; 2015 Apr; 3(4):314-22. PubMed ID: 25770404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
    Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
    Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.